Small molecule compound
Product Name
CAS Number
Specification
TP
DMF
Status
Clazosentan
180384-56-9
Q3 2025
Q1 2026
Dabrafenib mesylate
1195768-06-9
In-house
Q4 2025
Dapagliflozin
461432-26-8
USP, In-house
Darolutamide
1297538-32-9
Q4 2025
Q2 2026
Deucravacitinib
1609392-27-9
Q4 2025
Q2 2026
Deutivacaftor
1413431-07-8
Q1 2026
Q3 2026
Efinaconazole
164650-44-6
In-house
√
Elafibranor
923978-27-2
Q2 2026
Q1 2027
Elagolix sodium
832720-36-2
Q1 2026
Q3 2026
Elexacaftor
2216712-66-0
Q1 2026
Q3 2026
Eliglustat Tartrate
928659-70-5
In-house
√
Encorafenib
1269440-29-0
Q4 2025
Q2 2026
Entecavir Monohydrate
209216-23-9
USP, EP, in-house
√
Etrasimod
1206123-37-6
Q4 2025
Q2 2026
Febuxostat
144060-53-7
In-house
√
Fedratinib
936091-26-8
Q4 2025
Q2 2026
Finerenone
1050477-31-0
Q4 2025
Q2 2026
Fluvastatin sodium
93957-55-2
CP, USP, EP, JP
√
Galanthamine
357-70-0
EP, In-house
Q3 2025
Gilteritinib
1254053-43-4
Q4 2025
Q2 2026